NeuroSense Therapeutics Ltd. Warrant (NRSNW)
Official siteBIOTECHNOLOGY • NASDAQ
Last updated: Nov 16, 2026 at 4:00 PM ET
NeuroSense Therapeutics Ltd. Warrant (NRSNW) Stock Chart
NeuroSense Therapeutics Ltd. Warrant (NRSNW) closed at $0.01 on Nov 16, 2026, 98.7% below its 52-week high of $0.43. Its price fell 97.4% over the 12 months through Oct 2026. The month-end price fell 93.2% over the 3 years through Oct 2026, a compound annual decline of 59.3%.
Price Chart
From Dec 2021 to Oct 2026, its highest month-end close was $0.91 in Dec 2021 and its lowest $0.01 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NRSNW with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NRSNW.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 89.0%, and over 6 months it fell 92.5%.
| Period | Change |
|---|---|
| 1 month | -47.6% |
| 3 months | -89.0% |
| 6 months | -92.5% |
| Period | Change | Per year |
|---|---|---|
| 1 year | -97.4% | -97.4% |
| 3 years | -93.2% | -59.3% |
Price by Year
Its best calendar year was 2024, when the price rose 463.4%, and its weakest was 2022, when it fell 82.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.01 | -97.7% |
| 2025 | $0.32 | -27.3% |
| 2024 | $0.44 | +463.4% |
| 2023 | $0.08 | -51.5% |
| 2022 | $0.16 | -82.4% |
Trading Range
The price is 77.9% below its 50-day average of $0.02 and 95.1% below its 200-day average of $0.11.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 16, 2026) | $0.01 | |
| 52-week high | $0.43 | -98.7% |
| 52-week low | $0.00 | +400.0% |
| 50-day average | $0.02 | -77.9% |
| 200-day average | $0.11 | -95.1% |
Price Risk
Over 3 years, its largest fall from a peak was 99.4%.
| Measure | Value |
|---|---|
| 1-year beta | 3.10 |
| Largest fall, 1 year | -98.7% |
| Largest fall, 3 years | -99.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NRSNW
What is NRSNW's 1-year price change?
NeuroSense Therapeutics Ltd. Warrant's price fell 97.4% over the 12 months through Oct 2026.
How has NRSNW stock done over the long term?
NeuroSense Therapeutics Ltd. Warrant's month-end price fell 93.2% over the 3 years through Oct 2026, a compound annual decline of 59.3%. These figures leave out dividends.
What is NRSNW's 52-week high and low?
NeuroSense Therapeutics Ltd. Warrant's 52-week high is $0.43 and its 52-week low is $0.00. Its close of $0.01 on Nov 16, 2026 is 98.7% below the high.
What is NRSNW's beta?
NeuroSense Therapeutics Ltd. Warrant's 1-year beta against the S&P 500 is 3.10, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 98.7%.
Is the NRSNW chart free?
Yes. Advanced Charting for NRSNW is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NRSNW pages: Overview, Charting, Financials